244 related articles for article (PubMed ID: 29738578)
1. Cancer driver mutation prediction through Bayesian integration of multi-omic data.
Wang Z; Ng KS; Chen T; Kim TB; Wang F; Shaw K; Scott KL; Meric-Bernstam F; Mills GB; Chen K
PLoS One; 2018; 13(5):e0196939. PubMed ID: 29738578
[TBL] [Abstract][Full Text] [Related]
2. Identification of constrained cancer driver genes based on mutation timing.
Sakoparnig T; Fried P; Beerenwinkel N
PLoS Comput Biol; 2015 Jan; 11(1):e1004027. PubMed ID: 25569148
[TBL] [Abstract][Full Text] [Related]
3. A novel network control model for identifying personalized driver genes in cancer.
Guo WF; Zhang SW; Zeng T; Li Y; Gao J; Chen L
PLoS Comput Biol; 2019 Nov; 15(11):e1007520. PubMed ID: 31765387
[TBL] [Abstract][Full Text] [Related]
4. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
5. ConsensusDriver Improves upon Individual Algorithms for Predicting Driver Alterations in Different Cancer Types and Individual Patients.
Bertrand D; Drissler S; Chia BK; Koh JY; Li C; Suphavilai C; Tan IB; Nagarajan N
Cancer Res; 2018 Jan; 78(1):290-301. PubMed ID: 29259006
[TBL] [Abstract][Full Text] [Related]
6. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
7. A novel hypergraph model for identifying and prioritizing personalized drivers in cancer.
Zhang N; Ma F; Guo D; Pang Y; Wang C; Zhang Y; Zheng X; Wang M
PLoS Comput Biol; 2024 Apr; 20(4):e1012068. PubMed ID: 38683860
[TBL] [Abstract][Full Text] [Related]
8. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
[TBL] [Abstract][Full Text] [Related]
9. Multi-Omic Data Improve Prediction of Personalized Tumor Suppressors and Oncogenes.
Sudhakar M; Rengaswamy R; Raman K
Front Genet; 2022; 13():854190. PubMed ID: 35620468
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous identification of multiple driver pathways in cancer.
Leiserson MD; Blokh D; Sharan R; Raphael BJ
PLoS Comput Biol; 2013; 9(5):e1003054. PubMed ID: 23717195
[TBL] [Abstract][Full Text] [Related]
11. An Integrated Framework for Identifying Mutated Driver Pathway and Cancer Progression.
Zhang W; Wang SL
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(2):455-464. PubMed ID: 29990286
[TBL] [Abstract][Full Text] [Related]
12. Frequent mutations in acetylation and ubiquitination sites suggest novel driver mechanisms of cancer.
Narayan S; Bader GD; Reimand J
Genome Med; 2016 May; 8(1):55. PubMed ID: 27175787
[TBL] [Abstract][Full Text] [Related]
13. CanDrA: cancer-specific driver missense mutation annotation with optimized features.
Mao Y; Chen H; Liang H; Meric-Bernstam F; Mills GB; Chen K
PLoS One; 2013; 8(10):e77945. PubMed ID: 24205039
[TBL] [Abstract][Full Text] [Related]
14. CanDriS: posterior profiling of cancer-driving sites based on two-component evolutionary model.
Zhao W; Yang J; Wu J; Cai G; Zhang Y; Haltom J; Su W; Dong MJ; Chen S; Wu J; Zhou Z; Gu X
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33876217
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive assessment of computational algorithms in predicting cancer driver mutations.
Chen H; Li J; Wang Y; Ng PK; Tsang YH; Shaw KR; Mills GB; Liang H
Genome Biol; 2020 Feb; 21(1):43. PubMed ID: 32079540
[TBL] [Abstract][Full Text] [Related]
16. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
17. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
18. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
Elife; 2021 Jan; 10():. PubMed ID: 33427197
[TBL] [Abstract][Full Text] [Related]
19. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy.
Guo WF; Zhang SW; Liu LL; Liu F; Shi QQ; Zhang L; Tang Y; Zeng T; Chen L
Bioinformatics; 2018 Jun; 34(11):1893-1903. PubMed ID: 29329368
[TBL] [Abstract][Full Text] [Related]
20. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
